Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.05 | N/A |
PEG Ratio (TTM) | -0.13 | N/A |
P/S Ratio (TTM) | 0.57 | N/A |
P/B Ratio (TTM) | 3.32 | N/A |
P/FCF Ratio (TTM) | -14.59 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -4.03% | N/A |
ROE (TTM) | -44.78% | N/A |
Net Profit Margin (TTM) | -8.10% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -481.85% | -1,279.48% | N/A |
Revenue | -4.56% | 46.08% | N/A |
Net Income | -2,211.29% | -1,094.52% | N/A |
Cash Flow | -37.92% | -218.22% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.56 | N/A |
Quick Ratio (TTM) | 5.57 | N/A |
D/E Ratio (TTM) | 9.23 | N/A |
Interest Coverage (TTM) | -6.95 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 0.32 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |